Ok, we will be a little careful with this one. I knew ED was a hard problem, but Roman is raising a stiff (or maybe I should say smoking) $88 million to change its name to Ro and add smoking cessation services to its offerings. Not sure what ED and smoking have in common, but no more after-sex cigarettes for their ED customers.
http://fortune.com/2018/09/18/erectile-dysfunction-roman-funding/UnitedHealth Group offers us its survey results on consumer sentiment around health insurance issues.
Read More
The latest MEPS Statistical Brief from AHRQ describes physician visit characteristics and costs.
Read More
You will be pleased to know that Thirty Madison is rebuilding the health care experience for modern consumers and apparently is also fleecing modern investors, acquiring $15.25 million in new financing to create a platform to treat chronic conditions, although their primary product to date has been one that addresses baldness. Hope investors don’t take a haircut.
A new paper from the National Bureau of Economic Research looks at the effects of high patient cost-sharing on health spending growth.
Read More
The Lewin Group issues the final five-year evaluation of CMS' Medicare bundled payment initiative.
Read More
A study in Health Affairs finds that hospitals charge certain types of payers very high prices.
Read More
A report from Kaufman Hall on a survey of hospitals focuses on the status of cost transformation efforts.
Read More
Mandatory ratios about nurse staffing have no impact on outcomes, according to a new study.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.